Hjem › Kronisk inflammatorisk demyeliniserende polyradikuloneuropati › Texas
Kliniske studier for Kronisk inflammatorisk demyeliniserende polyradikuloneuropati i Texas
10 studier for Kronisk inflammatorisk demyeliniserende polyradikuloneuropati søker deltakere på steder i Texas.
Byer i Texas
Offisiell studietekst (engelsk)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1622, Houston
- Site Number - 1628, San Antonio
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Austin Neuromuscular Center, Austin
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05327114A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- National Neuromuscular Research Institute, Austin
- NeuroCarePlus, Houston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07091630A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- NeuroCarePlus, Houston
- National Neuromuscular Research Institute, Irving
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Austin Neuromuscular Center- Site Number : 8400040, Austin
- Gadolin Research - Beaumont- Site Number : 8400047, Beaumont
- Uthealth - The University Of Texas Health Sciences Center At Houston- Site Number : 8400050, Houston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06290141A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Advanced Neurology Epilepsy and Sleep Center/ANESC Research, El Paso
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06752356A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- GC2402 Study Site 106, Sherman
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, Dallas
- Clinical Study Site, Denton
- Cinical Study Site, Houston
- og 3 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06858579A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Houston Methodist Research Institute, Houston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. apr. 2026 · NCT06798012A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Neurology Rare Disease Center, Denton
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT06747351Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.